Multimorbidity in Pediatric Dermatology: Clinical Case
Authors:
- Nikolay N. MurashkinNMNikolay N. Murashkin
- Alexander I. MaterikinAMAlexander I. Materikin
- Eduard T. AmbarchianEAEduard T. Ambarchian
- Roman V. EpishevRERoman V. Epishev
- Leonid A. OpryatinLOLeonid A. Opryatin
- Roman A. IvanovRIRoman A. Ivanov
- Daria S. KukolevaDKDaria S. Kukoleva
- Daria G. KuptsovaDKDaria G. Kuptsova
- Alexander A. PushkovAPAlexander A. Pushkov
- Marina Yu. PomazanovaMPMarina Yu. Pomazanova
- Yana V. KozyrYKYana V. Kozyr
Open Access
- 27 December 2020
- journal article
- Published by Paediatrician Publishers LLC in Current Pediatrics
- Vol. 19 (6) , 483-489
Abstract
Background. Nowadays, dermatoses with mixed clinical picture and resistant to classical management become more common. The presence of various genetic disorders typical for most chronic dermatoses may indicate possible combination of several nosologies.Clinical Case Description. The article presents the clinical case of multimorbid condition in 10 years old patient who has nucleotide variants in CARD14 and EXPH5 genes. Mutations in CARD14 gene are typical for patients with type 2 psoriasis and pityriasis rubra pilaris (autosomal dominant type), while mutations in EXPH5 gene are typical for patients with non-specific epidermolysis bullosa (autosomal recessive type). Mutation in the TGM1 gene that is described in patients with congenital ichthyosis (autosomal recessive type), pathogenic mutations in KRT74 gene typical for ectodermal dysplasia, hypotrichosis and uncombable hair syndrome, and mutations in the KRT86 gene typical for monilethrix were also revealed. Medical history taking and histological examination as well as clinical data evaluating are crucial for correct diagnosis. They allow to understand the absence of the such manifestations in relatives and reveal various pathological processes in the epidermis. Molecular genetic testing with new generation sequencing (NGS) helps to finally establish the diagnosis and determine the further tactics for patient management.Conclusion. Multidisciplinary approach and use of high-technology methods of examination and treatment (such as molecular genetic testing and biological therapy) are required for final diagnosis in severe forms of chronic dermatosis resistant to treatment and for decision on correct tactics for the further management of such patients.Keywords
This publication has 15 references indexed in Scilit:
- Ustekinumab for the treatment of moderate‐to‐severe plaque psoriasis in paediatric patients (≥ 6 to < 12 years of age): efficacy, safety, pharmacokinetic and biomarker results from the open‐label CADMUS Jr studyBritish Journal of Dermatology, 2020
- Predicting perturbation patterns from the topology of biological networksProceedings of the National Academy of Sciences, 2018
- Tissue Specificity of Human Disease ModuleScientific Reports, 2016
- Hospitalization, inpatient burden and comorbidities associated with bullous pemphigoid in the U.S.A.British Journal of Dermatology, 2016
- Interventions for improving outcomes in patients with multimorbidity in primary care and community settingsCochrane Database of Systematic Reviews, 2016
- Understanding multicellular function and disease with human tissue-specific networksNature Genetics, 2015
- Clinical response to ustekinumab in familial pityriasis rubra pilaris caused by a novel mutation inCARD14British Journal of Dermatology, 2014
- The prevalence of multimorbidity in primary care and its effect on health care utilization and costFamily Practice, 2011
- Network medicine: a network-based approach to human diseaseNature Reviews Genetics, 2010
- A large-scale analysis of tissue-specific pathology and gene expression of human disease genes and complexesProceedings of the National Academy of Sciences, 2008